桃李麪包(603866.SH)披露2020年員工持股計劃(草案)
格隆匯2月2日丨桃李麪包(603866.SH)披露2020年員工持股計劃(草案),此員工持股計劃資金總額為不超過人民幣4億元,以"份"作為認購單位,每份份額為1.00元,員工持股計劃的份數上限為4億份。單個員工起始認購份數為1份(即認購金額為1.00元),單個員工必須認購1元的整數倍份額。
其中,參與此次員工持股計劃的高級管理人員合計認購份額不超過640萬份,佔員工持股計劃比例為1.60%;其他符合條件的員工合計認購份額不超過39,360萬份,佔員工持股計劃比例為98.40%。員工持股計劃存續期為48個月,自公司公告標的股票登記至當期員工持股計劃時起計算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.